Global Chagas Disease Drug Market Professional Survey Report 2017

January 2018 | 117 pages | ID: GC323F59B0DEN
QYResearch

Abstracts

This report studies Chagas Disease Drug in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

• AstraZeneca Plc
• Bayer AG
• Daiichi Sankyo Co Ltd
• Eisai Co Ltd
• GlaxoSmithKline Plc
• Grupo Praxis Pharmaceutical SA
• Humanigen Inc
• Kancera AB
• Merck & Co Inc
• Novartis AG
• Oblita Therapeutics BVBA
• Sanofi

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Cz-007
• Cz-008
• D-121
• DNDI-0690
• EPLBS-1246
• EPLBS-967
• Others

By Application, the market can be split into

• Hospital
• Clinic
• Others

By Regions, this report covers (we can add the regions/countries as you want)

• North America
• China
• Europe
• Southeast Asia
• Japan
• India

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Chagas Disease Drug Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF CHAGAS DISEASE DRUG

1.1 Definition and Specifications of Chagas Disease Drug
  1.1.1 Definition of Chagas Disease Drug
  1.1.2 Specifications of Chagas Disease Drug
1.2 Classification of Chagas Disease Drug
  1.2.1 Cz-007
  1.2.2 Cz-008
  1.2.3 D-121
  1.2.4 DNDI-0690
  1.2.5 EPLBS-1246
  1.2.6 EPLBS-967
  1.2.7 Others
1.3 Applications of Chagas Disease Drug
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF CHAGAS DISEASE DRUG

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Chagas Disease Drug
2.3 Manufacturing Process Analysis of Chagas Disease Drug
2.4 Industry Chain Structure of Chagas Disease Drug

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF CHAGAS DISEASE DRUG

3.1 Capacity and Commercial Production Date of Global Chagas Disease Drug Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global Chagas Disease Drug Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global Chagas Disease Drug Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global Chagas Disease Drug Major Manufacturers in 2016

4 GLOBAL CHAGAS DISEASE DRUG OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global Chagas Disease Drug Capacity and Growth Rate Analysis
  4.2.2 2016 Chagas Disease Drug Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global Chagas Disease Drug Sales and Growth Rate Analysis
  4.3.2 2016 Chagas Disease Drug Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global Chagas Disease Drug Sales Price
  4.4.2 2016 Chagas Disease Drug Sales Price Analysis (Company Segment)

5 CHAGAS DISEASE DRUG REGIONAL MARKET ANALYSIS

5.1 North America Chagas Disease Drug Market Analysis
  5.1.1 North America Chagas Disease Drug Market Overview
  5.1.2 North America 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.1.4 North America 2016 Chagas Disease Drug Market Share Analysis
5.2 China Chagas Disease Drug Market Analysis
  5.2.1 China Chagas Disease Drug Market Overview
  5.2.2 China 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.2.4 China 2016 Chagas Disease Drug Market Share Analysis
5.3 Europe Chagas Disease Drug Market Analysis
  5.3.1 Europe Chagas Disease Drug Market Overview
  5.3.2 Europe 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.3.4 Europe 2016 Chagas Disease Drug Market Share Analysis
5.4 Southeast Asia Chagas Disease Drug Market Analysis
  5.4.1 Southeast Asia Chagas Disease Drug Market Overview
  5.4.2 Southeast Asia 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.4.4 Southeast Asia 2016 Chagas Disease Drug Market Share Analysis
5.5 Japan Chagas Disease Drug Market Analysis
  5.5.1 Japan Chagas Disease Drug Market Overview
  5.5.2 Japan 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.5.4 Japan 2016 Chagas Disease Drug Market Share Analysis
5.6 India Chagas Disease Drug Market Analysis
  5.6.1 India Chagas Disease Drug Market Overview
  5.6.2 India 2012-2017E Chagas Disease Drug Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E Chagas Disease Drug Sales Price Analysis
  5.6.4 India 2016 Chagas Disease Drug Market Share Analysis

6 GLOBAL 2012-2017E CHAGAS DISEASE DRUG SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E Chagas Disease Drug Sales by Type
6.2 Different Types of Chagas Disease Drug Product Interview Price Analysis
6.3 Different Types of Chagas Disease Drug Product Driving Factors Analysis
  6.3.1 Cz-007 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.2 Cz-008 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.3 D-121 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.4 DNDI-0690 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.5 EPLBS-1246 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.6 EPLBS-967 of Chagas Disease Drug Growth Driving Factor Analysis
  6.3.7 Others of Chagas Disease Drug Growth Driving Factor Analysis

7 GLOBAL 2012-2017E CHAGAS DISEASE DRUG SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E Chagas Disease Drug Consumption by Application
7.2 Different Application of Chagas Disease Drug Product Interview Price Analysis
7.3 Different Application of Chagas Disease Drug Product Driving Factors Analysis
  7.3.1 Hospital of Chagas Disease Drug Growth Driving Factor Analysis
  7.3.2 Clinic of Chagas Disease Drug Growth Driving Factor Analysis
  7.3.3 Others of Chagas Disease Drug Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF CHAGAS DISEASE DRUG

8.1 AstraZeneca Plc
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 AstraZeneca Plc 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 AstraZeneca Plc 2016 Chagas Disease Drug Business Region Distribution Analysis
8.2 Bayer AG
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Bayer AG 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Bayer AG 2016 Chagas Disease Drug Business Region Distribution Analysis
8.3 Daiichi Sankyo Co Ltd
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Daiichi Sankyo Co Ltd 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Daiichi Sankyo Co Ltd 2016 Chagas Disease Drug Business Region Distribution Analysis
8.4 Eisai Co Ltd
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Eisai Co Ltd 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Eisai Co Ltd 2016 Chagas Disease Drug Business Region Distribution Analysis
8.5 GlaxoSmithKline Plc
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 GlaxoSmithKline Plc 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 GlaxoSmithKline Plc 2016 Chagas Disease Drug Business Region Distribution Analysis
8.6 Grupo Praxis Pharmaceutical SA
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 Grupo Praxis Pharmaceutical SA 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Grupo Praxis Pharmaceutical SA 2016 Chagas Disease Drug Business Region Distribution Analysis
8.7 Humanigen Inc
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Humanigen Inc 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Humanigen Inc 2016 Chagas Disease Drug Business Region Distribution Analysis
8.8 Kancera AB
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
    8.8.2.1 Product A
    8.8.2.2 Product B
  8.8.3 Kancera AB 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Kancera AB 2016 Chagas Disease Drug Business Region Distribution Analysis
8.9 Merck & Co Inc
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
    8.9.2.1 Product A
    8.9.2.2 Product B
  8.9.3 Merck & Co Inc 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Merck & Co Inc 2016 Chagas Disease Drug Business Region Distribution Analysis
8.10 Novartis AG
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
    8.10.2.1 Product A
    8.10.2.2 Product B
  8.10.3 Novartis AG 2016 Chagas Disease Drug Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 Novartis AG 2016 Chagas Disease Drug Business Region Distribution Analysis
8.11 Oblita Therapeutics BVBA
8.12 Sanofi

9 DEVELOPMENT TREND OF ANALYSIS OF CHAGAS DISEASE DRUG MARKET

9.1 Global Chagas Disease Drug Market Trend Analysis
  9.1.1 Global 2017-2022 Chagas Disease Drug Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 Chagas Disease Drug Sales Price Forecast
9.2 Chagas Disease Drug Regional Market Trend
  9.2.1 North America 2017-2022 Chagas Disease Drug Consumption Forecast
  9.2.2 China 2017-2022 Chagas Disease Drug Consumption Forecast
  9.2.3 Europe 2017-2022 Chagas Disease Drug Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 Chagas Disease Drug Consumption Forecast
  9.2.5 Japan 2017-2022 Chagas Disease Drug Consumption Forecast
  9.2.6 India 2017-2022 Chagas Disease Drug Consumption Forecast
9.3 Chagas Disease Drug Market Trend (Product Type)
9.4 Chagas Disease Drug Market Trend (Application)

10 CHAGAS DISEASE DRUG MARKETING TYPE ANALYSIS

10.1 Chagas Disease Drug Regional Marketing Type Analysis
10.2 Chagas Disease Drug International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Chagas Disease Drug by Region
10.4 Chagas Disease Drug Supply Chain Analysis

11 CONSUMERS ANALYSIS OF CHAGAS DISEASE DRUG

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL CHAGAS DISEASE DRUG MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Chagas Disease Drug
Table Product Specifications of Chagas Disease Drug
Table Classification of Chagas Disease Drug
Figure Global Production Market Share of Chagas Disease Drug by Type in 2016
Figure Cz-007 Picture
Table Major Manufacturers of Cz-007
Figure Cz-008 Picture
Table Major Manufacturers of Cz-008
Figure D-121 Picture
Table Major Manufacturers of D-121
Figure DNDI-0690 Picture
Table Major Manufacturers of DNDI-0690
Figure EPLBS-1246 Picture
Table Major Manufacturers of EPLBS-1246
Figure EPLBS-967 Picture
Table Major Manufacturers of EPLBS-967
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Chagas Disease Drug
Figure Global Consumption Volume Market Share of Chagas Disease Drug by Application in 2016
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Chagas Disease Drug by Regions
Figure North America Chagas Disease Drug Market Size (Million USD) (2012-2022)
Figure China Chagas Disease Drug Market Size (Million USD) (2012-2022)
Figure Europe Chagas Disease Drug Market Size (Million USD) (2012-2022)
Figure Southeast Asia Chagas Disease Drug Market Size (Million USD) (2012-2022)
Figure Japan Chagas Disease Drug Market Size (Million USD) (2012-2022)
Figure India Chagas Disease Drug Market Size (Million USD) (2012-2022)
Table Chagas Disease Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Chagas Disease Drug in 2016
Figure Manufacturing Process Analysis of Chagas Disease Drug
Figure Industry Chain Structure of Chagas Disease Drug
Table Capacity and Commercial Production Date of Global Chagas Disease Drug Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global Chagas Disease Drug Major Manufacturers in 2016
Table R&D Status and Technology Source of Global Chagas Disease Drug Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global Chagas Disease Drug Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of Chagas Disease Drug 2012-2017
Figure Global 2012-2017E Chagas Disease Drug Market Size (Volume) and Growth Rate
Figure Global 2012-2017E Chagas Disease Drug Market Size (Value) and Growth Rate
Table 2012-2017E Global Chagas Disease Drug Capacity and Growth Rate
Table 2016 Global Chagas Disease Drug Capacity (K Pcs) List (Company Segment)
Table 2012-2017E Global Chagas Disease Drug Sales (K Pcs) and Growth Rate
Table 2016 Global Chagas Disease Drug Sales (K Pcs) List (Company Segment)
Table 2012-2017E Global Chagas Disease Drug Sales Price (USD/Pcs)
Table 2016 Global Chagas Disease Drug Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure North America 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure North America 2016 Chagas Disease Drug Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure China 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure China 2016 Chagas Disease Drug Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure Europe 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure Europe 2016 Chagas Disease Drug Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure Southeast Asia 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure Southeast Asia 2016 Chagas Disease Drug Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure Japan 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure Japan 2016 Chagas Disease Drug Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Chagas Disease Drug 2012-2017E
Figure India 2012-2017E Chagas Disease Drug Sales Price (USD/Pcs)
Figure India 2016 Chagas Disease Drug Sales Market Share
Table Global 2012-2017E Chagas Disease Drug Sales (K Pcs) by Type
Table Different Types Chagas Disease Drug Product Interview Price
Table Global 2012-2017E Chagas Disease Drug Sales (K Pcs) by Application
Table Different Application Chagas Disease Drug Product Interview Price
Table AstraZeneca Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 AstraZeneca Plc Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 AstraZeneca Plc Chagas Disease Drug Business Region Distribution
Table Bayer AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Bayer AG Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Bayer AG Chagas Disease Drug Business Region Distribution
Table Daiichi Sankyo Co Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2015 Daiichi Sankyo Co Ltd Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Daiichi Sankyo Co Ltd Chagas Disease Drug Business Region Distribution
Table Eisai Co Ltd Information List
Table Product A Overview
Table Product B Overview
Table 2016 Eisai Co Ltd Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Eisai Co Ltd Chagas Disease Drug Business Region Distribution
Table GlaxoSmithKline Plc Information List
Table Product A Overview
Table Product B Overview
Table 2016 GlaxoSmithKline Plc Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 GlaxoSmithKline Plc Chagas Disease Drug Business Region Distribution
Table Grupo Praxis Pharmaceutical SA Information List
Table Product A Overview
Table Product B Overview
Table 2016 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Grupo Praxis Pharmaceutical SA Chagas Disease Drug Business Region Distribution
Table Humanigen Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Humanigen Inc Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Humanigen Inc Chagas Disease Drug Business Region Distribution
Table Kancera AB Information List
Table Product A Overview
Table Product B Overview
Table 2016 Kancera AB Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Kancera AB Chagas Disease Drug Business Region Distribution
Table Merck & Co Inc Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck & Co Inc Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Merck & Co Inc Chagas Disease Drug Business Region Distribution
Table Novartis AG Information List
Table Product A Overview
Table Product B Overview
Table 2016 Novartis AG Chagas Disease Drug Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2016 Novartis AG Chagas Disease Drug Business Region Distribution
Table Oblita Therapeutics BVBA Information List
Table Sanofi Information List
Figure Global 2017-2022 Chagas Disease Drug Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2017-2022 Chagas Disease Drug Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 Chagas Disease Drug Sales Price (USD/Pcs) Forecast
Figure North America 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2017-2022 Chagas Disease Drug Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Chagas Disease Drug by Type 2017-2022
Table Global Consumption Volume (K Pcs) of Chagas Disease Drug by Application 2017-2022
Table Traders or Distributors with Contact Information of Chagas Disease Drug by Region